Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey
- PMID: 26148821
- PMCID: PMC5144586
- DOI: 10.1017/S2045796015000566
Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey
Abstract
Background: The aim of this study is to estimate the lifetime and 12-month prevalence, severity and treatment of Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) mental disorders in Japan based on the final data set of the World Mental Health Japan Survey conducted in 2002-2006.
Methods: Face-to-face household interviews of 4130 respondents who were randomly selected from Japanese-speaking residents aged 20 years or older were conducted from 2002 to 2006 in 11 community populations in Japan (overall response rate, 56%). The World Mental Health version of the World Health Organization Composite International Diagnostic Interview (WMH-CIDI), a fully structured, lay administered psychiatric diagnostic interview, was used for diagnostic assessment.
Results: Lifetime/12-month prevalence of any DSM-IV common mental disorders in Japan was estimated to be 20.3/7.6%. Rank-order of four classes of mental disorders was anxiety disorders (8.1/4.9%), substance disorders (7.4/1.0%), mood disorders (6.5/2.3%) and impulse control disorders (2.0/0.7%). The most common individual disorders were alcohol abuse/dependence (7.3/0.9%), major depressive disorder (6.1/2.2%), specific phobia (3.4/2.3%) and generalized anxiety disorder (2.6/1.3%). While the lifetime prevalence of any mental disorder was greater for males and the middle-aged, the persistence (proportion of 12-month cases among lifetime cases) of any mental disorder was greater for females and younger respondents. Among those with any 12-month disorder, 15.3% were classified as severe, 44.1% moderate and 40.6% mild. Although a strong association between severity and service use was found, only 21.9% of respondents with any 12-month disorder sought treatment within the last 12 months; only 37.0% of severe cases received medical care. The mental health specialty sector was the most common resource used in Japan. Although the prevalence of mental disorders were quite low, mental disorders were the second most prevalent cause of severe role impairment among chronic physical and mental disorders.
Conclusions: These results suggest lower prevalence of mental disorders in Japan than that in Western countries, although the general pattern of disorders, risk factors and unmet need for treatment were similar to those in other countries. Greater lifetime prevalence for males and greater persistence for females seems a unique feature of Japan, suggesting a cultural difference in gender-related etiology and course of disorders. The treatment rate in Japan was lower than that in most other high-income countries in WMH surveys.
Keywords: Cross-sectional study; epidemiology; health service research; mental health.
Conflict of interest statement
R. Kessler has been a consultant for Hoffman-La Roche, Inc., Johnson & Johnson Wellness and Prevention, and Sanofi-Aventis Group. R. Kessler has served on advisory boards for Mensante Corporation, Plus One Health Management, Lake Nona Institute, and U.S. Preventive Medicine. R. Kessler owns 25% share in DataStat, Inc.
Similar articles
-
Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002-2003.Psychiatry Clin Neurosci. 2005 Aug;59(4):441-52. doi: 10.1111/j.1440-1819.2005.01397.x. Psychiatry Clin Neurosci. 2005. PMID: 16048450
-
Prevalence, treatment, and the correlates of common mental disorders in the mid 2010's in Japan: The results of the world mental health Japan 2nd survey.J Affect Disord. 2018 Dec 1;241:554-562. doi: 10.1016/j.jad.2018.08.050. Epub 2018 Aug 13. J Affect Disord. 2018. PMID: 30153639
-
Lifetime and 6-month prevalence of DSM-III-R psychiatric disorders in an urban community in Japan.Psychiatry Res. 2004 Jan 1;121(3):293-301. doi: 10.1016/s0165-1781(03)00239-7. Psychiatry Res. 2004. PMID: 14675748
-
Combat and peacekeeping operations in relation to prevalence of mental disorders and perceived need for mental health care: findings from a large representative sample of military personnel.Arch Gen Psychiatry. 2007 Jul;64(7):843-52. doi: 10.1001/archpsyc.64.7.843. Arch Gen Psychiatry. 2007. PMID: 17606818 Review.
-
The South Africa Stress and Health Study: rationale and design.Metab Brain Dis. 2004 Jun;19(1-2):135-47. doi: 10.1023/b:mebr.0000027424.86587.74. Metab Brain Dis. 2004. PMID: 15214513 Review.
Cited by
-
Diagnosis and Treatment of Generalized Anxiety Disorder in Japan: Psychiatric Specialist Survey.Neuropsychiatr Dis Treat. 2024 May 14;20:1001-1010. doi: 10.2147/NDT.S456276. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38764746 Free PMC article.
-
Comparison of changes in stress coping strategies between cognitive behavioral therapy and pharmacotherapy.Front Psychiatry. 2024 Apr 15;15:1343637. doi: 10.3389/fpsyt.2024.1343637. eCollection 2024. Front Psychiatry. 2024. PMID: 38686120 Free PMC article.
-
Panic disorder: Epidemiology, disability, and treatment gap from nationally representative general population of India.Indian J Psychiatry. 2023 Dec;65(12):1249-1253. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_825_23. Epub 2023 Dec 11. Indian J Psychiatry. 2023. PMID: 38298880 Free PMC article.
-
Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study.Neuropsychopharmacol Rep. 2024 Mar;44(1):149-157. doi: 10.1002/npr2.12411. Epub 2024 Jan 24. Neuropsychopharmacol Rep. 2024. PMID: 38267023 Free PMC article. Clinical Trial.
-
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.Neuropsychiatr Dis Treat. 2023 Nov 8;19:2401-2412. doi: 10.2147/NDT.S428443. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38029050 Free PMC article.
References
-
- Baxter AJ, Scott KM, Vos T, Whiteford HA (2013). Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychological Medicine 43, 897–910. - PubMed
-
- Bijl RV, de Graaf R, Hiripi E, Kessler RC, Kohn R, Offord DR, Ustun TB, Vicente B, Vollebergh WA, Walters EE, Wittchen HU (2003). The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) 22, 122–133. - PubMed
-
- Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, Polidori G, Kikkawa T, Kawakami N, Ono Y, Takeshima T, Uda H, Karam EG, Fayyad JA, Karam AN, Mneimneh ZN, Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang M, Alonso J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb C, Kessler RC, Merikangas KR, Anthony JC, Von Korff MR, Wang PS, Brugha TS, Aguilar-Gaxiola S, Lee S, Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S; WHO World Mental Health Survey Consortium (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Journal of American Medical Association 291, 2581–2590. - PubMed
-
- Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766–771. - PubMed
-
- Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA (2013). Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psycholgical Medicine 43, 471–481. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical